• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

CRM town hall

anonymous

Guest
Can we please stop with the 2 hour time waster CRM town halls? I realize management needs to justify their new roles, talk the big talk and rah, rah to make us little peons feel humble to be saved by Novartis. You say the same things on every town hall and still don't answer the field's questions to their satisfaction. Great job!
 

<



Also, you don’t address Veeva is a hot mess. New territory/targets didn’t download today, no announcement or global email of when will. Answer questions that were asked and don’t spend 2 hours talking about what shade of red each of your shirts are.